According to WHO, the vaccine should show a minimum level point estimate vaccine efficacy (VE) of 50 per cent in clinical trials, although a point estimate of 70 per cent is preferred. — Reuters pic. — Reuters pic

KUALA LUMPUR, Nov 29 — The Health Ministry (MoH), through the National Pharmaceutical Regulatory Agency (NPRA), will ensure that the Covid-19 vaccine approved to be registered and marketed in Malaysia is safe, of good quality and has optimum efficacy according to requirements set by the World Health Organisation (WHO).